Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders

By Basquiera Ana L.   Soria Néstor W.   Ryser Ricardo   Salguero Miriam   Moiraghi Beatriz   Sackmann Federico   Sturich Ana G.   Borello Adriana   Berretta Adriana   Bonafé Miriam   Barral José Moreno   Palazzo Emilio D.   García Juan J.  

Hematology, Vol. 14, Iss. 6, 2009-12 ,pp. : 323-330

Maney Publishing

Access to resources Recommend Favorite

JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Real‐Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2V617F mutation in Philadelphia‐negative chronic myeloproliferative neoplasms

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 6, 2015-12 ,pp. : 766-773

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular Events: A Challenge in JAK2-positive Myeloproliferative Neoplasms

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 17, Iss. 3, 2018-02 ,pp. : 161-166

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the association between the JAK2 46/1 haplotype and myeloproliferative neoplasm in a Korean population

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 4, 2015-08 ,pp. : e91-e95

John Wiley & Sons Inc

Access to resources Recommend Favorite